MEFIB vs. MAST and FAST: Not a competition but useful tools

J Hepatol. 2024 Jan;80(1):e35-e36. doi: 10.1016/j.jhep.2022.10.020. Epub 2022 Nov 10.

Authors

Mazen Noureddin¹, Stephen A Harrison², Naim Alkhouri³

Affiliations

¹ Houston Methodist Hospital, Houston, Texas, United States; Houston Research Institute, Houston, Texas, United States. Electronic address: noureddinmd@houstonresearchinstitute.com.
² Pinnacle Research, San Antonio, Texas, United Kingdom; Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
³ Arizona Liver Health, Phoenix, Arizona, United States.

PMID: 36370950
DOI: 10.1016/j.jhep.2022.10.020

No abstract available

Publication types

Letter
Comment